To understand the opportunities and barriers for evaluating services delivered in MS Ireland.
Has your activity changed since the start of the pandemic?
The MHRA (Medicines and Healthcare products Regulatory Agency) and European Commission have granted marketing authorisation for an under-the-skin injection of Tysabri. Tysabri is a disease-modifying therapy for highly active relapsing-remitting MS.
UK experts are set to run a multi-arm, multi-stage trial which will test a range of drugs already approved for other illnesses for the treatment of multiple sclerosis (MS). The ‘Octopus trial’ will allow three drugs to be tested at the same time.
All-Ireland MS Research Network (AIMS-RN) provides hope to those affected by multiple sclerosis
You are invited to participate in a study which will explore the perception of CBD oil.
Issue 7 is out now!
Lauren McCauley, person living with MS, patient advisor and a participant
Conducting research remotely by Fionnuala Rogers, Research Assistant at NUI Galway with the COB-MS feasibility trial.
A case study of anxiety in MS by Dr Rebecca Maguire - Associate Professor, Department of Psychology, Maynooth University